Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114874134A details a protection-free asymmetric synthesis of nicotine using Ir-catalysis, offering high ee values and scalable manufacturing for pharmaceutical intermediates.
Novel 3-step synthesis from 4-hydroxyquinoline avoids polyphosphoric acid. High yield, scalable process for pharmaceutical intermediates offering cost-effective manufacturing solutions.
Novel urea compound for diabetes research. Optimized synthesis route ensures supply continuity and cost efficiency for global pharmaceutical partners seeking reliable intermediates.
Novel enzymatic route for dabigatran intermediate offers high purity and cost efficiency for pharmaceutical manufacturing supply chains globally ensuring reliable production capacity.
Novel photocatalytic route for Zolpidem reduces steps and toxicity. Offers supply chain stability and cost efficiency for pharmaceutical manufacturers globally.
Patent CN118516426A reveals enzymatic route for chiral intermediates. High purity, mild conditions, cost-effective for pharma supply chains.
Patent CN106866392B reveals a novel base-catalyzed rearrangement of furfuryl alcohol. This method offers significant cost reduction and simplified purification for pharmaceutical intermediates manufacturing.
Discover the novel synthesis of 6-halo-caproic acid via 1,6-hexanediol halogenation and oxidation. A cost-effective, scalable route for pharmaceutical and agrochemical intermediates.
Patent CN101687796A details a robust Pd-catalyzed method for synthesizing heteroaryl alkynes using stable tosylates, offering significant cost and supply chain advantages for pharmaceutical intermediates.
Novel membrane bioreactor method ensures high purity Ezetimibe intermediate with reduced costs and scalable production for global pharmaceutical supply chains.
Novel Grignard-based route eliminates palladium catalysts, reducing costs and improving supply chain reliability for high-purity eczema treatment intermediates.
Patent CN111333495B discloses a potent antitumor benzophenone. Efficient Eaton reagent synthesis offers cost reduction in pharmaceutical intermediate manufacturing.
Patent CN102250005A details a novel chiral catalytic hydrogenation route for Eslicarbazepine, offering superior atom economy and simplified purification for API manufacturing.
Advanced synthesis method for cis-perhydroisoindole using lithium borohydride offers significant cost and safety advantages for pharmaceutical intermediate supply chains globally.
Patent CN108558636A details high-yield oxidation technology. Offers supply chain stability and cost efficiency for global pharmaceutical intermediate manufacturing needs and procurement.
Patent CN103467567B reveals high-yield synthesis for metalloprotease substrates. Enhances supply chain reliability and reduces manufacturing complexity for research teams.
Patent CN101875606A reveals a high-yield, ambient pressure route for 2,6-dihydroxyterephthalic acid, offering significant cost reduction and supply chain reliability for polymer manufacturers.
Patent CN116103255A details engineered KdAKR mutants for high-yield synthesis of tert-butyl 6-chloro-(3R,5S)-dihydroxyhexanoate, offering superior stereoselectivity and thermal stability for statin production.
Patent CN112110969B details a novel route for 3-nitro-7-azaindole triazole glycosides. Discover cost-effective synthesis and supply chain advantages for oncology APIs.
Novel Zn-N complex enables 99% transformation efficiency in Henry reactions. Reduces heavy metal waste significantly. Reliable supplier for high-purity pharma intermediates.